Accelerated Pharma (ACCP) Files 1.89M Share Common Stock IPO

October 11, 2016 2:31 PM EDT
Get Alerts ACCP Hot Sheet
Trade ACCP Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Accelerated Pharma (Nasdaq: ACCP) filed a registration with the U.S. SEC for an initial public offering of its common stock. The company plans to sell 1,888,889 shares of common stock and sees an offering price of $8 - $10 per share.

The offering will be made through Rodman & Renshaw and Maxim Group.

Accelerated Pharma is a clinical stage biopharmaceutical company focused on utilizing our genomic technology to (i) enhance the development of pre-existing pharmaceutical products for the treatment of various cancer indications, (ii) prospectively identify patients that may respond to such pharmaceutical products and (iii) commercialize such pharmaceutical products for sale in various markets.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Rodman & Renshaw, Maxim Group, IPO

Add Your Comment